| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0733-8619(05)70369-8 |
| P698 | PubMed publication ID | 9421543 |
| P2093 | author name string | Silberstein SD | |
| P2860 | cites work | Drug-induced headache | Q68633259 |
| The search for causes of idiopathic intracranial hypertension. A preliminary case-control study | Q68722316 | ||
| The role of stressful life events in the onset of chronic primary headache | Q68783236 | ||
| Aspartame and susceptibility to headache | Q69406380 | ||
| Transformation of episodic migraine into daily headache: analysis of factors | Q70372414 | ||
| Depression and headache | Q71795554 | ||
| Use and abuse of analgesics in tension-type headache | Q72133012 | ||
| Ergotamine abuse. Do patients benefit from withdrawal? | Q81259749 | ||
| Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs | Q28218775 | ||
| Drug induced refractory headache--clinical features and management | Q34032498 | ||
| Withdrawal syndrome after the double-blind cessation of caffeine consumption | Q34336987 | ||
| Classification of daily and near-daily headaches: proposed revisions to the IHS criteria | Q34337439 | ||
| The rational management of idiopathic intracranial hypertension | Q34510254 | ||
| Chronic analgesic-induced headache | Q34707441 | ||
| Repetitive intravenous DHE in the treatment of refractory headache | Q39517249 | ||
| Longterm prognosis of analgesic withdrawal in patients with drug-induced headaches | Q39522880 | ||
| Analgesic rebound headache | Q39564441 | ||
| Ergotamine dependency--a review | Q39597649 | ||
| Ergotamine abuse: results of ergotamine discontinuation, with special reference to the plasma concentrations | Q42265996 | ||
| Ergotamine-induced headache can be sustained by sumatriptan daily intake. | Q42280372 | ||
| Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): a case-control study | Q43517619 | ||
| Analgesic-induced chronic headache: long-term results of withdrawal therapy | Q44247834 | ||
| Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine | Q44729141 | ||
| Chronic pain, depression, and the dexamethasone suppression test | Q44925671 | ||
| Transformed or evolutive migraine | Q44957670 | ||
| The Tromsø Study: frequency and predicting factors of analgesic drug use in a free-living population (12-56 years). | Q48859373 | ||
| Biological markers for depression in chronic pain. | Q49138924 | ||
| The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. | Q50569051 | ||
| Repetitive intravenous dihydroergotamine as therapy for intractable migraine. | Q51807318 | ||
| Evaluation of chronic daily headache--comparison to criteria for chronic tension-type headache. | Q53392876 | ||
| Epidemiology of headache in a general population--a prevalence study. | Q53401181 | ||
| Drug-related headache. | Q53409121 | ||
| Ergotamine headache | Q66957672 | ||
| Chronic daily headache: long-term prognosis following inpatient treatment with repetitive IV DHE | Q67589985 | ||
| Overlap of Migraine and Tension-Type Headache in the International Headache Society Classification | Q67826765 | ||
| Analgesic rebound headache refuted | Q68039391 | ||
| Clinical features of chronic daily headache | Q68047015 | ||
| Medication Use and Disability Among Migraineurs: A National Probability Sample Survey | Q68203874 | ||
| Does analgesic abuse cause headaches de novo? | Q68268193 | ||
| P433 | issue | 1 | |
| P921 | main subject | headache | Q86 |
| P304 | page(s) | 107-123 | |
| P577 | publication date | 1998-02-01 | |
| P1433 | published in | Neurologic Clinics | Q15756619 |
| P1476 | title | Drug-induced headache | |
| P478 | volume | 16 |
| Q57992554 | Are There Predictive Factors for Long-Term Outcome after Withdrawal in Drug-Induced Chronic Daily Headache? |
| Q38167677 | Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review |
| Q43050704 | Migraine recurrence is not associated with depressive or anxiety symptoms. Results of a randomized controlled trial |
Search more.